About Carlos Bonilla

This author has not yet filled in any details.
So far Carlos Bonilla has created 20 blog entries.

FDA Unveils Final Interchangeability Guidance for Biosimilars

The FDA has finally released its guidance on biosimilar interchangeability. Radar on Specialty Pharmacy speaks with Ryan Cox, Precision for Value Vice President, Access Experience team on how the new guidelines reduce administrative hurdles and duplicative clinical trials. However, he notes that reimbursement issues may discourage uptake.

LEARN MORE

FDA Unveils Final Interchangeability Guidance for Biosimilars2020-03-13T15:13:07-04:00

CBO says Proposed Rule to Kill Rebates Will Increase Spending by $177 Billion

Increasing patient savings and reducing government spending are laudable goals. But neither the CBO nor Precision experts Jeremy Schafer, Jacki Chou, and Harry G. Schiavi believe the proposed HHS rule will work. In this Spotlight on Market Access article, they join other industry leaders in discussing the potential repercussions of the rule.

LEARN MORE

CBO says Proposed Rule to Kill Rebates Will Increase Spending by $177 Billion2020-03-13T15:13:28-04:00

CBO says Proposed Rebate Rule Will Cost Government $177B

HHS wants to eliminate drug rebates in Medicare Part D and Medicaid managed care. But the CBO projects the resulting higher premiums will cost the government dearly. In an AIS Health, Radar on Specialty Pharmacy article, Jeremy Schafer, Precision for Value Senior Vice President, Access Experience, weighs in on the potential impact of the rule, and what that means for its future.

LEARN MORE

CBO says Proposed Rebate Rule Will Cost Government $177B2020-03-13T15:13:52-04:00

Generic Advair May Help COPD Costs, but Management is Tough

When high out-of-pocket costs spur noncompliance that leads to increased hospitalization, payers take notice. Using therapies for COPD as a case in point, AIS Health, Radar on Drug Benefits interviews Precision for Value Vice President, Access Experience, Charline Shan about the strategies payers may take to lower costs for their beneficiaries—and themselves.

LEARN MORE

Generic Advair May Help COPD Costs, but Management is Tough2020-03-13T15:14:26-04:00

Precision for Value Taps Payer Veterans to Join Market-Leading Access Experience Team

Precision for Value, part of Precision Value & Health, the market leader in supporting global pharmaceutical and life science companies in demonstrating the value and outcomes of innovative medical products, today announced further strategic expansion of its Access Experience Team with the hiring of former payer and integrated delivery network (IDN) decision makers Ryan Cox, Dan Danielson, and Erin Lopata.

LEARN MORE

Precision for Value Taps Payer Veterans to Join Market-Leading Access Experience Team2020-03-13T15:15:16-04:00
Precision Medicine Group

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

© Precision Medicine Group, LLC. All Rights Reserved.   Privacy | GDPR